Abstract
The HIV epidemic in Latin America: a time to reflect on the history of success and the challenges ahead.
Highlights
From 2003 to 2008, the number of people on antiretroviral therapy (ART) doubled and steadily increased afterwards; by 2017, approximately 1.2 million people living with HIV (PLHIV) (61%) were receiving ART, lagging only after high-income countries (78%) [1]
The estimated 2 million people who inject drugs living in Latin America have been neglected despite being one of the groups with the highest HIV prevalence (7.4%) [15]
During the 38 years of the HIV/AIDS epidemic, we have learned that it can be fuelled in environments where human rights for vulnerable populations are limited
Summary
From 2003 to 2008, the number of people on ART doubled and steadily increased afterwards; by 2017, approximately 1.2 million PLHIV (61%) were receiving ART, lagging only after high-income countries (78%) [1]. There is an almost complete absence of reliable data on access to HIV and harm reduction services, which has made it difficult to design, fund and implement evidence-based strategies to reduce HIV incidence among people who inject drugs in the region [16].
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
